Key result
High-flux polyamide membrane dialysis significantly decreased beta2-microglobulin levels and attenuated the progression of aortic stiffness, but did not modify other inflammatory indices or lipid profiles compared to low-flux membranes.
Why the study?
Does high-flux polyamide membrane hemodialysis improve inflammatory indices and aortic stiffness compared to low-flux polyamide membrane in stable anuric hemodialysis patients?
RCT (n=46)
Single-blind
Stratified by duration of dialysis and diabetes status
Yes
Does high-flux polyamide membrane hemodialysis improve inflammatory indices and aortic stiffness compared to low-flux polyamide membrane in stable anuric hemodialysis patients?
p-value: p=NS
In stable hemodialysis patients, high-flux polyamide membranes do not significantly alter inflammatory or lipid profiles compared to low-flux membranes, but they may beneficially reduce the progression of aortic stiffness.
High-flux polyamide membranes may slow aortic stiffness progression in hemodialysis without altering inflammation or lipids; extends membrane flux effects to vascular outcomes.
BACKGROUND AND OBJECTIVES: Both larger molecule removal and dialyzer biocompatibility have been implicated in the high-flux hemodialysis (HD)-associated favorable outcome. In an attempt to delineate the effect of membrane permeability, we performed a randomized, crossover study to compare the inflammatory biomarkers, lipid profile, and aortic pulse wave velocity (PWV) of two dialyzers that are composed of identical membranes but with different flux characteristics. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Stable patients who had anuria and were on low-flux polysulfone membrane were randomly allocated either to HD with high-flux polyamide membrane (group A; 22 patients) or to HD with low-flux polyamide membrane (group B; 24 patients) for 24 weeks, then they were started on 24 weeks of the alternative HD treatment. Apart from the dialyzer, the dialysis prescription remained unchanged. RESULTS: Nineteen patients from group A and 23 patients from group B completed the study. Predialysis beta(2)-microglobulin levels decreased significantly when using the high-flux polyamide membrane. No difference between membranes was observed for serum albumin, high-sensitivity C-reactive protein, fibrinogen, IL-6, triglycerides, HDL cholesterol, LDL cholesterol, and lipoprotein(a) during the study. A significant increase in aortic PWV, a marker of aortic stiffness, was noted after patients switched from high-flux to low-flux polyamide membranes. Similarly, the rate of change in aortic PWV was significantly decreased with the use of the high-flux polyamide membrane. CONCLUSIONS: Our findings suggest that dialysis with polyamide membranes with different flux characteristics did not modify the inflammatory indices and lipid profile in stable HD patients; however, a seemingly beneficial effect on aortic stiffness was noted for patients who were maintained on high-flux polyamide membrane.
No takes yet. Share an insight, caveat, or question.
Li et al. (2010) conducted an RCT in End-stage renal disease on hemodialysis (n=46). High-flux polyamide membrane (Polyflux 14S) vs. Low-flux polyamide membrane (Polyflux 6L) was evaluated on Differences in inflammatory indices (including hs-CRP) (p=NS). High-flux polyamide membrane dialysis significantly decreased beta2-microglobulin levels and attenuated the progression of aortic stiffness, but did not modify other inflammatory indices or lipid profiles compared to low-flux membranes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: